Healthcor Management LP Has Raised Celgene (CELG) Position, Veritable LP Upped Unilever N V (UN) Holding

May 31, 2017 - By Winifred Garcia

Veritable Lp increased Unilever N V (UN) stake by 6.13% reported in 2016Q4 SEC filing. Veritable Lp acquired 7,996 shares as Unilever N V (UN)’s stock rose 12.65%. The Veritable Lp holds 138,484 shares with $5.69 million value, up from 130,488 last quarter. Unilever N V now has $168.46B valuation. The stock rose 0.60% or $0.34 reaching $56.78 per share. About 1.92 million shares traded or 10.34% up from the average. Unilever NV (ADR) (NYSE:UN) has risen 26.55% since May 31, 2016 and is uptrending. It has outperformed by 9.85% the S&P500.

Healthcor Management Lp increased Celgene Corp (CELG) stake by 942.75% reported in 2016Q4 SEC filing. Healthcor Management Lp acquired 1.36M shares as Celgene Corp (CELG)’s stock declined 3.49%. The Healthcor Management Lp holds 1.50 million shares with $173.63M value, up from 143,850 last quarter. Celgene Corp now has $87.89B valuation. The stock declined 0.83% or $0.95 reaching $114.18 on the news. About 2.27M shares traded. Celgene Corporation (NASDAQ:CELG) has risen 17.00% since May 31, 2016 and is uptrending. It has outperformed by 0.30% the S&P500.

Veritable Lp decreased Enterprise Prods Partners L (NYSE:EPD) stake by 15,924 shares to 733,892 valued at $19.84M in 2016Q4. It also reduced Vanguard World Fds (VDE) stake by 25,383 shares and now owns 175,320 shares. Vanguard Bd Index Fd Inc (BND) was reduced too.

Among 9 analysts covering Unilever NV (NYSE:UN), 5 have Buy rating, 0 Sell and 4 Hold. Therefore 56% are positive. Unilever NV had 10 analyst reports since September 25, 2015 according to SRatingsIntel. On Monday, March 27 the stock rating was reinitiated by Liberum Capital with “Hold”. The stock of Unilever NV (ADR) (NYSE:UN) has “Buy” rating given on Wednesday, August 31 by Citigroup. The company was downgraded on Wednesday, December 7 by JP Morgan. The firm has “Buy” rating given on Tuesday, December 13 by Jefferies. The stock of Unilever NV (ADR) (NYSE:UN) earned “Outperform” rating by Bernstein on Monday, August 22. Credit Suisse upgraded Unilever NV (ADR) (NYSE:UN) on Tuesday, December 8 to “Neutral” rating. The stock has “Overweight” rating by Barclays Capital on Friday, March 24. The stock of Unilever NV (ADR) (NYSE:UN) has “Overweight” rating given on Tuesday, January 12 by JP Morgan. The firm has “Sector Perform” rating given on Friday, July 22 by RBC Capital Markets. The stock of Unilever NV (ADR) (NYSE:UN) has “Buy” rating given on Friday, September 25 by Berenberg.

Since February 27, 2017, it had 0 insider buys, and 3 selling transactions for $3.15 million activity. VESSEY RUPERT sold $497,672 worth of stock or 4,000 shares. The insider KAPLAN GILLA sold $1.74 million. 7,500 shares were sold by CASEY MICHAEL D, worth $911,625 on Monday, February 27.

Healthcor Management Lp decreased Zimmer Biomet Hldgs Inc (ZMH) stake by 375,240 shares to 674,760 valued at $69.64 million in 2016Q4. It also reduced Merck & Co Inc (NYSE:MRK) stake by 232,530 shares and now owns 567,470 shares. Pra Health Sciences Inc was reduced too.

Among 23 analysts covering Celgene Corporation (NASDAQ:CELG), 18 have Buy rating, 0 Sell and 5 Hold. Therefore 78% are positive. Celgene Corporation had 40 analyst reports since July 21, 2015 according to SRatingsIntel. JMP Securities maintained the shares of CELG in report on Friday, July 24 with “Mkt Outperform” rating. The firm earned “Buy” rating on Thursday, February 25 by Citigroup. The firm has “Buy” rating given on Friday, November 6 by UBS. The company was maintained on Thursday, September 29 by Citigroup. The company was initiated on Friday, July 15 by Stifel Nicolaus. The stock of Celgene Corporation (NASDAQ:CELG) earned “Outperform” rating by Wells Fargo on Friday, December 4. The rating was initiated by Leerink Swann on Friday, February 5 with “Market Perform”. BTIG Research downgraded the stock to “Neutral” rating in Wednesday, June 1 report. The rating was maintained by UBS on Friday, July 24 with “Buy”. The stock of Celgene Corporation (NASDAQ:CELG) earned “Buy” rating by Standpoint Research on Thursday, January 14.